Y Combinator Partner discusses biotech fundraising by comparing changes to other technologies a decade ago

Jared Friedman, a Partner in Y Combinator, writes that “that raising money for a biotech or other life science company in 2019 looks a lot like raising money for a tech company 10 years ago.” How is that trend likely to play-out for life science companies over the next decade? He offers his thoughts here.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.